CIK: 0001773206
Total reported value
$2.1B
Reporting period: 2026-03-31 · Number of holdings: 90
Integral Health Asset Management, LLC disclosed 90 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $2.1B and a quarterly turnover rate of 69.3%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "I"
Integral Health Asset Management, LLC's disclosed holdings carry a Herfindahl concentration index of 0.047 — mathematically equivalent to about 21 equally-sized positions, well below its 90 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 1.76), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 66% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add RVMD
+129.2% $171.9M
Trim ISRG
-68.2% -$46.2M
Add CYTK
+36.8% $50.6M
Add ROIV
+135.3% $37.0M
Trim CVS
-70.0% -$28.9M
Trim VERA
-11.1% -$26.8M
Showing top 86 holdings (of 90 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | Stock-Healthcare | 12.79% | +8.04% | +129.17% | |
| 2 | INSM | Insmed INC | Stock-Healthcare | 11.73% | +0.93% | +20.00% | |
| 3 | CYTK | Cytokinetics INC | Stock-Healthcare | 8.20% | +2.21% | +36.84% | |
| 4 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 3.14% | -0.88% | -19.05% | |
| 5 | VERA | Vera Therapeutics INC | Stock-Other | 3.08% | -1.45% | -11.11% | |
| 6 | CAH | Cardinal Health INC | Stock-Healthcare | 2.73% | +0.69% | +35.00% | |
| 7 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 2.65% | +1.73% | +135.29% | |
| 8 | BTSG | Brightspring Health Services | Stock-Other | 2.55% | +1.16% | +66.67% | |
| 9 | RYTM | Rhythm Pharmaceuticals INC | Stock-Other | 2.50% | — | +26.32% | |
| 10 | MRK | Merck & Co. INC. | Stock-Healthcare | 2.45% | +1.13% | +70.00% | |
| 11 | EWTX | Edgewise Therapeutics INC | Stock-Other | 2.41% | +0.56% | +6.67% | |
| 12 | AZN | AstraZeneca PLC | Stock-Healthcare | 2.36% | +2.36% | NEW | |
| 13 | ALHC | Alignment Healthcare INC | Stock-Other | 2.17% | — | +17.05% | |
| 14 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 1.83% | — | — | |
| 15 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.65% | +0.58% | +144.44% | |
| 16 | MLYS | Mineralys Therapeutics INC | Stock-Other | 1.62% | — | +25.00% | |
| 17 | LFST | Lifestance Health Group INC | Stock-Other | 1.31% | — | +43.33% | |
| 18 | ASND | Ascendis Pharma A/S | Stock-Other | 1.26% | — | +27.78% | |
| 19 | SRRK | Scholar Rock Holding CORP | Stock-Other | 1.18% | +0.52% | +66.67% | |
| 20 | ELV | Elevance Health INC | Stock-Healthcare | 1.05% | — | +25.00% | |
| 21 | CNC | Centene CORP | Stock-Healthcare | 1.02% | — | — | |
| 22 | BBIO | Bridgebio Pharma INC | Stock-Healthcare | 0.98% | +0.98% | NEW | |
| 23 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 0.95% | — | — | |
| 24 | GKOS | Glaukos CORP | Stock-Healthcare | 0.90% | -0.92% | -46.15% | |
| 25 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 0.90% | +0.57% | +200.00% | |
| 26 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 0.85% | +0.85% | NEW | |
| 27 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 0.85% | — | +16.67% | |
| 28 | ALMS | Alumis INC | Stock-Other | 0.84% | +0.84% | NEW | |
| 29 | FMS | Fresenius Medical Care-adr | Stock-Other | 0.84% | — | +19.23% | |
| 30 | ISRG | Intuitive Surgical INC | Stock-Healthcare | 0.77% | -2.32% | -68.18% | |
| 31 | QURE | uniQure N.V. | Stock-Other | 0.70% | — | — | |
| 32 | TARS | Tarsus Pharmaceuticals INC | Stock-Other | 0.67% | — | — | |
| 33 | GILD | Gilead Sciences INC | Stock-Healthcare | 0.67% | +0.67% | NEW | |
| 34 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.66% | — | -25.00% | |
| 35 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 0.65% | -0.73% | -47.69% | |
| 36 | COGT | Cogent Biosciences INC | Stock-Other | 0.64% | +0.64% | NEW | |
| 37 | ELAN | Elanco Animal Health INC | Stock-Healthcare | 0.63% | — | +120.00% | |
| 38 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 0.63% | +0.63% | NEW | |
| 39 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.62% | — | — | |
| 40 | DNTH | Dianthus Therapeutics INC | Stock-Other | 0.60% | — | -45.45% | |
| 41 | RGNX | Regenxbio INC | Stock-Other | 0.60% | — | +25.00% | |
| 42 | DGX | Quest Diagnostics INC | Stock-Healthcare | 0.56% | — | -20.00% | |
| 43 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 0.56% | +0.56% | NEW | |
| 44 | ERAS | Erasca INC | Stock-Other | 0.54% | +0.54% | NEW | |
| 45 | ANRO | Alto Neuroscience INC | Stock-Other | 0.54% | — | +33.33% | |
| 46 | BIIB | Biogen INC | Stock-Healthcare | 0.53% | — | -40.00% | |
| 47 | DXCM | Dexcom INC | Stock-Healthcare | 0.53% | -1.12% | -65.00% | |
| 48 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 0.52% | — | — | |
| 49 | IRON | Disc Medicine INC | Stock-Other | 0.52% | +0.52% | NEW | |
| 50 | NRIX | Nurix Therapeutics INC | Stock-Other | 0.52% | — | +133.33% |
Performance for Q3 2026
+12.4%
Performance Last 4 Quarters
+54.1%
Based on 87% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 90 | $2.1B | 69 | |
| 2025-12-31 | 86 | $2.0B | 68 | |
| 2025-09-30 | 76 | $1.5B | 88 | |
| 2025-06-30 | 72 | $1.1B | 0 | |
| 2025-03-31 | 81 | $939.8M | 100 | |
| 2024-12-31 | 83 | $1.2B | 0 | |
| 2024-09-30 | 66 | $888.7M | 0 | |
| 2024-06-30 | 72 | $1.1B | 0 | |
| 2024-03-31 | 80 | $1.1B | 0 | |
| 2023-12-31 | 69 | $734.3M | 0 | |
| 2023-09-30 | 65 | $722.3M | 0 | |
| 2023-06-30 | 73 | $807.6M | 0 | |
| 2023-03-31 | 71 | $496.4M | 0 | |
| 2022-12-31 | 61 | $476.4M | 0 | |
| 2022-09-30 | 65 | $514.8M | 0 | |
| 2022-06-30 | 65 | $486.2M | 0 | |
| 2022-03-31 | 71 | $384.3M | 0 | |
| 2021-12-31 | 71 | $361.4M | 0 | |
| 2021-09-30 | 70 | $347.9M | 0 | |
| 2021-06-30 | 71 | $363.2M | 84 | |
| 2021-03-31 | 69 | $350.0M | 84 | |
| 2020-12-31 | 57 | $336.2M | 85 | |
| 2020-09-30 | 72 | $327.0M | 86 | |
| 2020-06-30 | 60 | $333.9M | 100 | |
| 2020-03-31 | 51 | $227.0M | 100 | |
| 2019-12-31 | 50 | $256.8M | 0 |
Integral Health Asset Management, LLC's most significant position changes for 2026-03-31: Sold out: Medtronic plc (MDT); New buy: AstraZeneca PLC (AZN); Sold out: Astrazeneca Plc-spons Adr (AZNN); Sold out: Teva Pharmaceutical-sp Adr (TEVA); Sold out: Penumbra INC (PEN).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | +8% | +129.17% | Add |
| 2 | CYTK | Cytokinetics INC | +2.2% | +36.84% | Add |
| 3 | ROIV | Roivant Sciences Ltd. | +1.7% | +135.29% | Add |
| 4 | BTSG | Brightspring Health Services | +1.2% | +66.67% | Add |
| 5 | MRK | Merck & Co. INC. | +1.1% | +70.00% | Add |
| 6 | INSM | Insmed INC | +0.9% | +20.00% | Add |
| 7 | CAH | Cardinal Health INC | +0.7% | +35.00% | Add |
| 8 | BSX | Boston Scientific CORP | +0.6% | +144.44% | Add |
| 9 | ARWR | Arrowhead Pharmaceuticals In | +0.6% | +200.00% | Add |
| 10 | EWTX | Edgewise Therapeutics INC | +0.6% | +6.67% | Add |
| 11 | SRRK | Scholar Rock Holding CORP | +0.5% | +66.67% | Add |
| 12 | BEAM | Beam Therapeutics INC | -0.4% | -45.45% | Trim |
| 13 | BHVN | Biohaven Ltd. | -0.4% | -33.33% | Trim |
| 14 | EW | Edwards Lifesciences CORP | -0.7% | -47.69% | Trim |
| 15 | COO | Cooper Cos Inc/the | -0.8% | -53.85% | Trim |
| 16 | REGN | Regeneron Pharmaceuticals | -0.9% | -19.05% | Trim |
| 17 | GKOS | Glaukos CORP | -0.9% | -46.15% | Trim |
| 18 | DXCM | Dexcom INC | -1.1% | -65.00% | Trim |
| 19 | CVS | Cvs Health CORP | -1.5% | -70.00% | Trim |
| 20 | VERA | Vera Therapeutics INC | -1.5% | -11.11% | Trim |
| 21 | ISRG | Intuitive Surgical INC | -2.3% | -68.18% | Trim |
| 22 | MDT | Medtronic plc | — | EXIT | Sold out |
| 23 | AZN | AstraZeneca PLC | — | NEW | New buy |
| 24 | AZNN | Astrazeneca Plc-spons Adr | — | EXIT | Sold out |
| 25 | TEVA | Teva Pharmaceutical-sp Adr | — | EXIT | Sold out |
| 26 | PEN | Penumbra INC | — | EXIT | Sold out |
| 27 | TFX | Teleflex INC | — | EXIT | Sold out |
| 28 | ALNY | Alnylam Pharmaceuticals INC | — | EXIT | Sold out |
| 29 | IRTC | Irhythm Holdings INC | — | EXIT | Sold out |
| 30 | BBIO | Bridgebio Pharma INC | — | NEW | New buy |
| 31 | UPB | Upstream Bio INC | — | EXIT | Sold out |
| 32 | THC | Tenet Healthcare CORP | — | EXIT | Sold out |
| 33 | VRTX | Vertex Pharmaceuticals INC | — | NEW | New buy |
| 34 | DOCS | Doximity Inc-class A | — | EXIT | Sold out |
| 35 | ALMS | Alumis INC | — | NEW | New buy |
| 36 | 430 | Terns Pharmaceuticals INC | — | EXIT | Sold out |
| 37 | UNH | Unitedhealth Group INC | — | EXIT | Sold out |
| 38 | RDNT | Radnet INC | — | EXIT | Sold out |
| 39 | GILD | Gilead Sciences INC | — | NEW | New buy |
| 40 | COGT | Cogent Biosciences INC | — | NEW | New buy |
| 41 | MDGL | Madrigal Pharmaceuticals INC | — | NEW | New buy |
| 42 | ACLXGBX | Arcellx INC | — | EXIT | Sold out |
| 43 | XENE | Xenon Pharmaceuticals INC | — | NEW | New buy |
| 44 | ERAS | Erasca INC | — | NEW | New buy |
| 45 | IRON | Disc Medicine INC | — | NEW | New buy |
| 46 | EHC | Encompass Health CORP | — | EXIT | Sold out |
| 47 | TMO | Thermo Fisher Scientific INC | — | NEW | New buy |
| 48 | LIVN | LivaNova PLC | — | NEW | New buy |
| 49 | IONS | Ionis Pharmaceuticals INC | — | NEW | New buy |
| 50 | CRL | Charles River Laboratories | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-17 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-11 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-09 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-13 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-03 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-12 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-02 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-12 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-30 | Amendment | View on EDGAR |
| 2021-06-30 | 2021-08-13 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-10 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-16 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-15 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-13 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001662449
Total reported value
$2.1B
332 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001843228
Total reported value
$2.1B
28 stks
2021-09-30
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001103646
Total reported value
$2.1B
961 stks
2026-03-31
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001389574
Total reported value
$1.4B
205 stks
2026-03-31
2 of the top 5 holdings overlap, including Insmed INC
CIK 0001599882
Total reported value
$810.5M
86 stks
2026-03-31
2 of the top 5 holdings overlap, including Regeneron Pharmaceuticals
CIK 0001839209
Total reported value
$3.8B
6 stks
2026-03-31
2 of the top 5 holdings overlap, including Insmed INC